157 related articles for article (PubMed ID: 17929117)
21. Classification and Reporting of Late Radiographic Changes After Lung Stereotactic Body Radiotherapy: Proposing a New System.
Raziee H; Hope A; Faruqi S; Yap ML; Roberts H; Kandel S; Le LW; Brade A; Cho J; Sun A; Bezjak A; Giuliani ME
Clin Lung Cancer; 2015 Nov; 16(6):e245-51. PubMed ID: 26077096
[TBL] [Abstract][Full Text] [Related]
22. Early stage non-small cell lung cancer treated with pencil beam scanning particle therapy: retrospective analysis of early results on safety and efficacy.
Chen J; Lu JJ; Ma N; Zhao J; Chen C; Fan M; Jiang G; Mao J
Radiat Oncol; 2019 Jan; 14(1):16. PubMed ID: 30683133
[TBL] [Abstract][Full Text] [Related]
23. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
[TBL] [Abstract][Full Text] [Related]
24. Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer.
Mattonen SA; Palma DA; Haasbeek CJ; Senan S; Ward AD
Med Phys; 2014 Mar; 41(3):033502. PubMed ID: 24593744
[TBL] [Abstract][Full Text] [Related]
25. Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis.
Kim TH; Woo S; Halpenny DF; Kim YJ; Yoon SH; Suh CH
Eur J Radiol; 2020 Jun; 127():108978. PubMed ID: 32298960
[TBL] [Abstract][Full Text] [Related]
26. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors.
Diot Q; Kavanagh B; Schefter T; Gaspar L; Stuhr K; Miften M
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1024-30. PubMed ID: 22583607
[TBL] [Abstract][Full Text] [Related]
27. Radiation-induced lung injury patterns and the misdiagnosis after SBRT of lung cancer.
Zhu X; Li X; Gu H; Yu W; Fu X
Eur J Radiol; 2019 Dec; 121():108708. PubMed ID: 31704600
[TBL] [Abstract][Full Text] [Related]
28. The Fate of Residual Tumor Masses That Persist After Stereotactic Body Radiotherapy for Solitary Lung Nodules: Will They Recur?
Takenaka R; Shibamoto Y; Miyakawa A; Hashizume C; Baba F
Clin Lung Cancer; 2016 Sep; 17(5):406-411. PubMed ID: 26781347
[TBL] [Abstract][Full Text] [Related]
29. Outcome Study of Cobalt Based Stereotactic Body Radiation Therapy for Patients with Inoperable Stage III Non-small Cell Lung Cancer.
Wang Y; Lan F; Kang X; Shao Y; Li H; Li P; Wu W; Wang J; Chang D; Wang Y; Xia T
Technol Cancer Res Treat; 2015 Oct; 14(5):539-45. PubMed ID: 24750001
[TBL] [Abstract][Full Text] [Related]
30. Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy.
Vinogradskiy Y; Diot Q; Kavanagh B; Schefter T; Gaspar L; Miften M
Med Phys; 2013 Aug; 40(8):081712. PubMed ID: 23927309
[TBL] [Abstract][Full Text] [Related]
31. Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study.
Sumita K; Harada H; Asakura H; Ogawa H; Onoe T; Murayama S; Nakamura S; Tanigawa N; Takahashi T; Nishimura T
Radiat Oncol; 2016 Aug; 11():104. PubMed ID: 27485533
[TBL] [Abstract][Full Text] [Related]
32. A Histologic Basis for the Efficacy of SBRT to the lung.
Woody NM; Stephans KL; Andrews M; Zhuang T; Gopal P; Xia P; Farver CF; Raymond DP; Peacock CD; Cicenia J; Reddy CA; Videtic GM; Abazeed ME
J Thorac Oncol; 2017 Mar; 12(3):510-519. PubMed ID: 28017592
[TBL] [Abstract][Full Text] [Related]
33. Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors.
Parker SM; Siochi RA; Wen S; Mattes MD
Pract Radiat Oncol; 2019 Jan; 9(1):e90-e97. PubMed ID: 30267899
[TBL] [Abstract][Full Text] [Related]
34. Radiation Pneumonitis Changes over Time after Stereotactic Body Radiation Therapy for Lung Tumors: Post-treatment Cavity (Sunny-side-up Egg-like) Changes.
Maebayashi T; Ishibashi N; Aizawa T; Sakaguchi M; Sato T; Kawamori J; Tanaka Y
Anticancer Res; 2016 Oct; 36(10):5563-5570. PubMed ID: 27798931
[TBL] [Abstract][Full Text] [Related]
35. A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer.
Munoz-Schuffenegger P; Kandel S; Alibhai Z; Hope A; Bezjak A; Sun A; Simeonov A; Cho BCJ; Giuliani M
Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):720-727. PubMed ID: 31176537
[TBL] [Abstract][Full Text] [Related]
36. Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer: Implications for Surveillance.
Spratt DE; Wu AJ; Adeseye V; Din SU; Shaikh F; Woo KM; Zhang Z; Foster A; Rosenzweig KE; Gewanter R; Huang J; Rimner A
Clin Lung Cancer; 2016 May; 17(3):177-183.e2. PubMed ID: 26602271
[TBL] [Abstract][Full Text] [Related]
37. Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.
Hearn JW; Videtic GM; Djemil T; Stephans KL
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):402-6. PubMed ID: 25017480
[TBL] [Abstract][Full Text] [Related]
38. Lung metastases in oligometastatic patients: outcome with stereotactic body radiation therapy (SBRT).
García-Cabezas S; Bueno C; Rivin E; Roldán JM; Palacios-Eito A
Clin Transl Oncol; 2015 Aug; 17(8):668-72. PubMed ID: 26022130
[TBL] [Abstract][Full Text] [Related]
39. Imaging characteristics of local recurrences after stereotactic body radiation therapy for stage I non-small cell lung cancer: Evaluation of mass-like fibrosis.
Hayashi S; Tanaka H; Hoshi H
Thorac Cancer; 2015 Mar; 6(2):186-93. PubMed ID: 26273357
[TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
